Wat betsjut "Dúdlik"?
It bist draacht de mutaasje net. It sil de sykte net ûntwikkelje en sil it net trochjaan.
The Von Willebrand Disease II Variant 2 (vWDII-2) DNA test in dogs is essential for identifying genetic mutations linked to this inherited bleeding disorder. Early detection through this test helps breeders make informed decisions to reduce the risk of passing vWDII-2 to offspring. This condition affects blood clotting, leading to prolonged bleeding and potential health complications in affected dogs. By using the vWDII-2 DNA test, veterinarians and breeders can ensure better management and care for at-risk dogs. Accurate genetic screening supports responsible breeding practices and promotes healthier canine populations. If you own a breed prone to Von Willebrand Disease, consider this test for peace of mind. Stay proactive in your dog's health with the vWDII-2 DNA test today.
The Von Willebrand Disease II Variant 2 (vWDII-2) is a genetic disorder affecting dogs, leading to impaired blood clotting. This DNA test identifies carriers and affected dogs by detecting mutations in the von Willebrand factor gene. Early diagnosis through testing helps manage bleeding risks during surgery or injury. Breeders use the test to make informed mating decisions and reduce disease prevalence. Overall, the vWDII-2 DNA test is a valuable tool for canine health and breeding programs.
Dizze DNA-test is opnommen fanôf ús pakket Basic - en is ek diel fan 'e pakketten Basic, Standard, Advanced, Complete.
Besjoch DNA-testpakketten →Von Willebrand Disease (vWD) is a blood clotting disorder that affects various species, including dogs. The condition is caused by a deficiency or dysfunction of von Willebrand factor (vWF), a protein crucial for platelet adhesion during the blood clotting process. Among the different variants of vWD, Variant 2 (vWDII-2) is characterized by a qualitative defect in vWF, leading to bleeding complications in affected animals.
Dogs with vWDII-2 may exhibit a range of clinical signs primarily related to bleeding tendencies. These signs can vary in severity and may include excessive bleeding from minor injuries, prolonged bleeding after surgery, nosebleeds, and spontaneous bruising. In some cases, affected dogs may show signs of anemia due to significant blood loss. It is important for pet owners to recognize these symptoms and seek veterinary advice if they suspect their dog may be affected.
The diagnosis of Von Willebrand Disease II Variant 2 typically involves a combination of clinical assessment and laboratory testing. While a DNA test can confirm the presence of the genetic variant associated with vWDII-2, additional tests such as platelet function assays and vWF antigen levels are often conducted to evaluate the dog’s bleeding tendency. A comprehensive approach is essential for accurate diagnosis and management of the condition.
Management of vWDII-2 focuses on minimizing the risk of bleeding and addressing any bleeding episodes that may occur. This may involve avoiding certain surgical procedures that pose a high risk of bleeding, as well as providing supportive care during emergencies. In some cases, desmopressin (DDAVP), a synthetic hormone, may be administered to stimulate the release of stored vWF from platelets and endothelial cells, thereby improving clotting ability. Regular monitoring and a tailored management plan are essential for maintaining the health of affected dogs.
Von Willebrand Disease II Variant 2 is a significant hereditary condition that requires awareness and proactive management. Understanding the symptoms, diagnostic processes, and treatment options available can assist pet owners and veterinarians in making informed decisions for the health and well-being of affected dogs. Regular veterinary check-ups and discussions about genetic testing can also play a vital role in preventing and managing this bleeding disorder.
It bist draacht de mutaasje net. It sil de sykte net ûntwikkelje en sil it net trochjaan.
Nee, it bist is oer it algemien sûn, mar kin de mutaasje oerjaan oan har neiteam.
It draacht twa mutearre eksimplaren. Klinyske tekens wurde ferwachte ôfhinklik fan de sykte. It moat net fokt wurde.
Guon sykten binne seks-keppele, sadat harren útdrukking fariearret ôfhinklik fan de bist syn seks.
This DNA test detects the mutation associated with Von Willebrand Disease Ii Variant 2 (vWDII-2) in order to identify clear, carrier, or at-risk animals.
DNA-testen helpt fokkers om feiliger parings te plannen en it risiko te ferminderjen fan it oerdragen fan de mutaasje nei neiteam.
De erflike modus rapportearre foar dizze test is Autosomal Recessive.
This test analyses the mutation VWF c.4937A>G.
Net needsaaklik. Ynterpretaasje hinget ôf fan it erflik patroan en de resultearjende genotyp.
Kramer J W, Venta P J, Klein S R, Cao Y, Schall W D, YuzbasiyanGurkan V. A von Willebrand's factor genomic nucleotide variant and polymerase chain reaction diagnostic test associated with inheritable type-2 von Willebrand's disease in a line of german shorthaired pointer dogs. Vet Pathol. 2004 May;41(3):221-8. doi: 10.1354/vp.41-3-221.
Jo privacy, jo kar
Wy brûke essensjele cookies om de webside út te fieren. Opsjonele cookies (lykas oanbieders fan ynbêde ynhâld) binne standert útskeakele en binne allinich ynskeakele as jo it iens binne. Jo kinne jo kar op elk momint feroarje mei de knop "Koekjes".
Fereaske foar kearnfunksjes en feiligens. Altyd ynskeakele.
Ferbetteret funksjes lykas foarkarbesparring of net-reklame-ynbêden.
Helpt ús sitegebrûk te begripen. Standert útskeakele.
Advertearje / folgjen oer siden (guon fideo / kaarten ynbêde). Standert útskeakele.